Literature DB >> 22946282

Ovarian function and in vitro fertilization (IVF) in Turner syndrome.

Outi Hovatta1.   

Abstract

Normal numbers of oocytes and ovarian follicles develop to the ovaries during the first half of the fetal life. The oocytes then start gradually disappearing. Abnormal meiotic division due to the lack of a paring X-chromosome has been suggested as the causative factor. A large proportion, 40-50% of Turner girls have at least some pubertal development, and about 10% may undergo menarche. Ovarian follicles have been found in some 40% of teenagers with Turner syndrome. Serum concentrations of antimullerian hormone (AMH) and follicle stimulation hormone (FSH), karyotype with mosaicism or structural chromosomal abnormalities, and spontaneous onset of pubertal development are positive prognostic signs for the presence of oocytes and ovarian function. Spontaneous pregnancies occur in some 2-10% of Turner women, a higher number than estimated earlier. This is probably due to failed identification of the syndrome among Turner women with ovarian function. Premature ovarian failure (POF) at some age can be expected in most of Turner women. FSH-stimulated oocyte retrieval and IVF can be carried out before predicted POF. Counseling not to postpone childbearing unnecessarily is advisable. Collected oocytes can be cryopreserved using vitrification, and stored until a pregnancy is desired. Large number of primordial oocytes within ovarian follicles can be stored in within superficial biopsied pieces of ovarian cortical tissue, for transplantation back to the ovary later on. Oocyte donation is an effective infertility treatment for Turner women who have undergone POF. Adequate hormonal replacement therapy (HRT) before IVF is necessary. Only one embryo at a time should be transferred particularly to these women in order to avoid pregnancy complications. Pregnancies in Turner syndrome women have high risks. Comprehensive health control including MRI of the aorta is recommended already before a planned pregnancy, and aorta has to be followed up by echography at least twice during the pregnancy to evaluate the risk of aortic dissection. Some 30% of Turner women develop hypertension during pregnancy, but this is also common among all oocyte donation pregnancies.

Entities:  

Mesh:

Year:  2012        PMID: 22946282

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  8 in total

Review 1.  Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments.

Authors:  K Oktay; G Bedoschi
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-09-10       Impact factor: 1.814

Review 2.  Reproductive Issues in Women with Turner Syndrome.

Authors:  Lisal J Folsom; John S Fuqua
Journal:  Endocrinol Metab Clin North Am       Date:  2015-09-03       Impact factor: 4.741

Review 3.  A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency.

Authors:  A Falorni; V Minarelli; C M Eads; C M Joachim; L Persani; R Rossetti; P Yurttas Beim; V A Pellegrini; P F Schnatz; S Rafique; K Kissell; K A Calis; V Popat; L M Nelson
Journal:  Panminerva Med       Date:  2014-10-07       Impact factor: 5.197

Review 4.  Fertility preservation for genetic diseases leading to premature ovarian insufficiency (POI).

Authors:  Antonio La Marca; Elisa Mastellari
Journal:  J Assist Reprod Genet       Date:  2021-01-25       Impact factor: 3.412

5.  Concurrent insulinoma with mosaic Turner syndrome: A case report.

Authors:  Shaoyun Wang; Lijuan Yang; Jie Li; Yiming Mu
Journal:  Exp Ther Med       Date:  2015-01-05       Impact factor: 2.447

6.  Reproductive and obstetric outcomes in mosaic Turner's Syndrome: a cross-sectional study and review of the literature.

Authors:  Emek Doğer; Yiğit Çakıroğlu; Yasin Ceylan; Esen Ulak; Özkan Özdamar; Eray Çalışkan
Journal:  Reprod Biol Endocrinol       Date:  2015-06-10       Impact factor: 5.211

7.  Clinical and genetic characteristics in a group of 45 patients with Turner syndrome (monocentric study).

Authors:  Simona Bucerzan; Diana Miclea; Radu Popp; Camelia Alkhzouz; Cecilia Lazea; Ioan Victor Pop; Paula Grigorescu-Sido
Journal:  Ther Clin Risk Manag       Date:  2017-05-04       Impact factor: 2.423

8.  Chromosomal Aberrations in Primary Amenorrhea: A Retrospective Study.

Authors:  Seema Korgaonkar; Somprakash Dhangar; Vinayak Kulkarni; Lily Kerketta; Babu Rao Vundinti
Journal:  J Hum Reprod Sci       Date:  2019 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.